93 related articles for article (PubMed ID: 7946680)
1. Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma. Comparison with CT during arterial portography.
Kamba M; Suto Y; Kato T
Acta Radiol; 1994 Nov; 35(6):570-5. PubMed ID: 7946680
[TBL] [Abstract][Full Text] [Related]
2. A study of chondroitin sulfate iron colloid as a liver specific MR contrast agent.
Hussain MZ; Ohtomo K; Kachi K; Uchiyama G; Itai Y
Radiat Med; 1994; 12(1):1-5. PubMed ID: 8016397
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
Suto Y; Kato T; Matsuo T; Kamba M; Shimatani Y; Ohuchi Y; Nakamura K; Ohta Y
Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
[TBL] [Abstract][Full Text] [Related]
4. Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma.
Suto Y; Kodama F; Kamba M; Ohta Y
Acta Radiol; 1995 Jan; 36(1):102-5. PubMed ID: 7833161
[TBL] [Abstract][Full Text] [Related]
5. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma.
Suto Y; Shimatani Y; Kato T; Kamba M; Ohuchi Y; Kodama F; Kato T; Ohta Y
Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691
[TBL] [Abstract][Full Text] [Related]
6. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H
AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
[TBL] [Abstract][Full Text] [Related]
7. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
8. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
Suto Y; Ametani M; Kamba M; Sugihara S
Br J Radiol; 1996 Mar; 69(819):201-5. PubMed ID: 8800862
[TBL] [Abstract][Full Text] [Related]
9. Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma.
Suto Y; Shimatani Y
Br J Radiol; 1995 Feb; 68(806):116-20. PubMed ID: 7735739
[TBL] [Abstract][Full Text] [Related]
10. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced mr imaging versus combined helical CT during arterial portography and CT hepatic arteriography.
Choi D; Kim S; Lim J; Lee W; Jang H; Lee S; Lim H
AJR Am J Roentgenol; 2001 Feb; 176(2):475-82. PubMed ID: 11159099
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of superparamagnetic iron oxide particles in the detection of hepatocellular carcinoma by MR imaging].
Hirohashi S; Uchida H; Ohimichi R; Kitano S; Tanaka M; Ohishi H
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):469-71. PubMed ID: 8388092
[TBL] [Abstract][Full Text] [Related]
12. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.
Heiken JP; Weyman PJ; Lee JK; Balfe DM; Picus D; Brunt EM; Flye MW
Radiology; 1989 Apr; 171(1):47-51. PubMed ID: 2538862
[TBL] [Abstract][Full Text] [Related]
13. Optimum conditions for iron colloid enhanced fast spin echo imaging in hepatocellular carcinoma.
Sugihara S; Suto Y; Yoshida K
Br J Radiol; 1997 Aug; 70(836):791-7. PubMed ID: 9486042
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of multislice dynamic MR imaging of the whole liver].
Inoue E; Kuroda C; Fujita M; Hosomi N; Kadota T; Narumi Y; Kuriyama K; Yoshioka H; Kasugai H; Sasaki Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Apr; 54(5):363-70. PubMed ID: 8190605
[TBL] [Abstract][Full Text] [Related]
15. CT and MR imaging of hepatocellular carcinoma.
Bolog N; Andreisek G; Oancea I; Mangrau A
J Gastrointestin Liver Dis; 2011 Jun; 20(2):181-9. PubMed ID: 21725516
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of spiral CT in the detection of hypovascular, well-differentiated hepatocellular carcinoma].
Fujita M; Kuroda C; Inoue E; Kumatani T; Hosomi N; Narumi Y; Kuriyama K; Kadota T; Kasugai H; Sasaki Y; Ishiguro S
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Mar; 56(4):155-9. PubMed ID: 8992449
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma exhibiting a concentric structure of different histologic grades: evaluation by chondroitin sulfate iron colloid-enhanced MR imaging.
Kamba M; Suto Y; Kodama F; Ohta Y; Kobayashi J; Horie Y; Kawasaki H
J Magn Reson Imaging; 1996; 6(2):406-8. PubMed ID: 8859586
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.
Hori M; Murakami T; Oi H; Kim T; Takahashi S; Matsushita M; Tomoda K; Narumi Y; Kadowaki K; Nakamura H
Acta Radiol; 1998 Mar; 39(2):144-51. PubMed ID: 9529444
[TBL] [Abstract][Full Text] [Related]
19. MR imaging during arterial-portography (MR-AP) in the detection of hepatic tumor: comparison with CT-AP.
Kajiya Y; Nakajo M; Miyazono N; Kajiya Y; Fujiyoshi F; Ichinari N
Radiat Med; 1997; 15(6):361-5. PubMed ID: 9495785
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT.
Kanematsu M; Osada S; Amaoka N; Goshima S; Kondo H; Moriyama N
Abdom Imaging; 2006; 31(1):78-89. PubMed ID: 16317488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
